204 related articles for article (PubMed ID: 16292090)
1. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication.
Duman DG; Bor S; Ozütemiz O; Sahin T; Oğuz D; Iştan F; Vural T; Sandkci M; Işksal F; Simşek I; Soytürk M; Arslan S; Sivri B; Soykan I; Temizkan A; Beşşk F; Kaymakoğlu S; Kalayc C
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1357-61. PubMed ID: 16292090
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Seddik H; Boutallaka H; Elkoti I; Nejjari F; Berraida R; Berrag S; Loubaris K; Sentissi S; Benkirane A
Eur J Clin Pharmacol; 2019 May; 75(5):639-645. PubMed ID: 30694338
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
4. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
Hurduc V; Plesca D; Dragomir D; Sajin M; Vandenplas Y
Acta Paediatr; 2009 Jan; 98(1):127-31. PubMed ID: 18681892
[TBL] [Abstract][Full Text] [Related]
5. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
[TBL] [Abstract][Full Text] [Related]
6. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Kotowska M; Albrecht P; Szajewska H
Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
[TBL] [Abstract][Full Text] [Related]
7. [Influence of different timing of
He CX; Kong FT; Liang F; Wang KX; Li H; Liu YL; Zhao W; Zhou PP; Kong FL
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1731-1734. PubMed ID: 31216821
[No Abstract] [Full Text] [Related]
8. Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection.
Zhang Y; Lu B; Dong Y; Zhang Y; Du Q; Chen Y; Zhang Z
Sci Rep; 2024 Jun; 14(1):13152. PubMed ID: 38849408
[TBL] [Abstract][Full Text] [Related]
9. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial.
Naghibzadeh N; Salmani F; Nomiri S; Tavakoli T
BMC Gastroenterol; 2022 Mar; 22(1):107. PubMed ID: 35255819
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment.
Szajewska H; Horvath A; Piwowarczyk A
Aliment Pharmacol Ther; 2010 Nov; 32(9):1069-79. PubMed ID: 21039671
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation.
Sjomina O; Poļaka I; Suhorukova J; Vangravs R; Paršutins S; Knaze V; Park JY; Herrero R; Murillo R; Leja M
Eur J Cancer Prev; 2024 May; 33(3):217-222. PubMed ID: 37942999
[TBL] [Abstract][Full Text] [Related]
12. [A multicenter randomized controlled study of
Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Ramas M; Donday MG; McNicholl AG; Gisbert JP
Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
15. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
Georgopoulos SD; Ladas SD; Karatapanis S; Triantafyllou K; Spiliadi C; Mentis A; Artikis V; Raptis SA
Aliment Pharmacol Ther; 2002 Mar; 16(3):569-75. PubMed ID: 11876712
[TBL] [Abstract][Full Text] [Related]
17. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
18. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
[TBL] [Abstract][Full Text] [Related]
19. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
